Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Tab-cel
Tab-cel
ASH: With PhIII data in hand, Atara eyes a submission to treat a small but desperate group of transplant patients
Endpoints
Mon, 12/13/21 - 11:47 pm
ASH2021
Atara
tabelecleucel
Tab-cel
EBV
Upcoming events – Atara and Aslan await validating results
EP Vantage
Fri, 08/2/19 - 10:40 am
Atara
Tab-cel
ATA188
multiple sclerosis
Aslan
varlitinib